Home
Product
Applications and Technologies
Application tree diagram
Technology
Resource center
Application picture
Meeting
Online training video
Publications
File download
About us
Company introduction
Team introduction
Blog
Contact us
Model: Anti-HER2 drugs (e.g., trastuzumab)-induced cardiomyopathy
Ultrasound assessment: Subclinical cardiac dysfunction (reduced EF/FS), abnormal myocardial strain
Model: Doxorubicin- or paclitaxel-induced cardiac injury
Ultrasound assessment: LV hypertrophy, diastolic dysfunction, myocardial lipid deposition
Model: High-fat diet-induced obese mice or leptin-deficient (ob/ob) mice
Ultrasound assessment: Early diastolic dysfunction, myocardial fibrosis (strain analysis)
Model: STZ-induced diabetic rats or db/db mice
Ultrasound assessment: Cardiac structural abnormalities, abnormal blood flow (e.g., shuntin
Model: Gene editing (e.g., Tbx5 knockout) causing ventricular septal defects or aortic coarctation
Ultrasound assessment: Myocardial hypertrophy, chamber dilation, decreased systolic function
Model: Hypertrophic cardiomyopathy (HCM) transgenic mice (e.g., Myh6 mutation), dilated cardiomyopathy (DCM) models
Model: Renal hypertensive rats (e.g., 2K1C model) or spontaneously hypertensive rats (SHR)
Obtain A Quotation